Member Info for Muck165

Seems like a well matched pick to me.

For info, Northern Bear last accounts show he was on £120k a year there. If we’re paying anything similar to that I reckons it’s a decent deal for us.

So, California has now declared a state of emergency over bird flu.

https://nypost.com/2024/12/18/us-news/california-declares-state-of-emergency-as-us-suffers-first-severe-human-case-of-bird-flu/?utm_campaign=nypost&utm_medium=referral

Time for me to stop banging on about this!

The WHO published new draft pre qualification testing criteria for at home syphillis tests today. You can read it here, and it will be relevant to us I think in relation to FOFH.

https://extranet.who.int/prequal/sites/default/files/document_files/tss-27_syphilis-selftest.pdf

But that’s not why I’m posting it.

Instead you can just see from this 43 page doc just how detailed the requirements are, and any test developer with limited resource or expertise would I’m sure face it with terror and trepidation!

But that is precisely the space that our new analytical, and beefed up regulatory teams are targeting. No wonder we’re looking to charge FOFH up to $2m to go through the process (albeit for 4 tests), and having the ability to do that work, in addition to all the other services, can only make us a more attractive total offering to our target customer base (at least imo).

Me neither, and I doubt it will be much more than a few days delay owing to entirely normal reasons anyway.

Funny thing is the auditors have just been re-appointed by AGM vote. If there was any significant issue with us or them, you wouldn’t think either side would want to continue.

It’s a nothing issue as far as I’m concerned.

So, earlier this year they were cautiously optimistic about achieving profitability by end of year.

By September they were "currently expecting" to meet its end of year profitability target

Now we know they achieved it early, by the end of November, and are looking forward to continuing progress.

And......accounts to June 30 are in line with market expectations.

And we have a potentially lucrative tie up with advanced AI targeting the growing video advertising market through CIQ.

Been frantic today so only just seen this - thanks Teraferma.

Amazing news to get Oz approval. But more interesting (to me at least) is they say Salignostics has achieved 500,000 unit sales/orders since launch. That is some way north of the last figure I can remember anyone letting slip, and our slice of each unit sale must be pretty meaningful given we make part of the test as well as provide kitting and distribution services for it. Looks like it might be starting to significantly help that manufacturing revenue annuity underpin Yates has often talked about.

Rather, nobody is really selling despite the hike in the bid. Plenty more to come here I think.

Remaining bullish isn't he! And that's just based on the TA and ignores the impending news we're hoping for.

Feels to me like she's itching to break 6, with a decent buy (10m) going through at that price earlier.

Bit surprised not to get an AGM results RNS this morning, so suspect that will come intraday or tomorrow, with results (and hopefully some forward looking statements) by Friday at the latest.

Good news will see this pop imho.

Hi PW - glad to see you’re still in and well done on the trade yesterday!

I know it’s a cliche, but next year is looking promising for me. I still think the TU will show weaker trading in H1 (as it always does), but in H2 typically brings a flurry of news leading into FY TU in July. I’m expecting the US office to open, new FD/NED, news on Upfront (hopefully NHS adoption), news on 52N, hopefully Loop commercial traction, possibly more with Boots, and then of course details of any new deals. Finally, there is Bird Flu skulking in the dark which, if it does become a problem, will no doubt increase interest here even if we didn’t have anything in the pipe. On that, remember too we have been invited to meetings with the UKHSA in respect of their “100 day” pandemic preparedness mission.

As we’ve often said the foundations are there, we just need to build on them.

Https://www.theguardian.com/commentisfree/2024/dec/16/bird-flu-pandemic-threat-prepared

I’m leaning that way too, but it would be nice to get confirmation!

It would also be reassuring to know more about FOFH (and how it’s funded). Most developers in their position have a website and strong social media interaction, but we know very little about them.

Whatever, this is great news today.

Not to detract from what is excellent news, but one unanswered question is whether we will be paid in cash, or in equity (as before).

And nice to see the Doncaster lab open. I’m starting to see the value in Analytical services. Without it we could make money up to transfer to manufacturing, but then there would be a lengthy hiatus while the developer went for approval. Now we have the opportunity to get paid during that period as well.

Oh, and the £2m contract value represents about 25% of what Yates said ABDX breakeven was (before the 2 acquisitions this year)

Well, I was wrong about no meaningful news before the TU! It’s a nice contract win although I have to wonder why regulatory work is only just beginning.

As Yates points out though, the significant thing is that FOFH are using every one of our services.

SwiftR Bio posted this today

https://www.linkedin.com/posts/swiftr-bio_study-reveals-that-drinking-raw-milk-can-activity-7274481433493090306-1q_1?utm_source=share&utm_medium=member_desktop

It’s got to be pointed out that we have had no confirmation from the company that we’re involved with Folium - aka Swiftr Bio, at all, but there have been very strong indications that we are, going back 12 months.

Swiftr was the original name for a salmonella test, but it appears to have grown into its own brand of molecular rapid tests for the detection of various pathogens in animals. From the piece I can’t tell if they have an HN51 test in the pipe, but they’d be daft not to have, and I suspect they have.

If they have a test I can’t say if ABDX is involved, but then of course they are scientists with zero experience of rapid test development and manufacturing process, or capability. They would need a CDMO.

Bird flu hasn’t really hit mainstream news, but scientists ARE worried. Every day there is some new piece about it. Some examples here.

https://www.lemonde.fr/en/opinion/article/2024/12/15/america-s-handling-of-the-bird-flu-crisis-is-putting-and-will-continue-to-put-the-entire-world-at-risk_6736100_23.html

https://www.kcrw.com/culture/shows/second-opinion/the-risk-of-a-bird-flu-epidemic

https://www.bbc.co.uk/news/articles/cp8327xw6zgo

This one is starting to really tweak my interest (well, from an investment perspective at least - nobody wants another pandemic).

I’m no Chartist, but I fid see that the 20DMA crossed the 200 last week, and the 50DMA is close to doing the same. A golden cross with volume should tweak traders interest, which on top of (hopefully) good news could make the rest of this week interesting.

For anyone interested….

0M was originally incorporated in Sept last year by one Erol Soyer. It looks like Napier then bought it in May and appointed one Andrew Mole to be CEO.

Soyer’s Linkedin page shows that he started a business called Aperon TV at about the same time he set up 0M. That business appears to be doing exactly the same thing as 0M/CIQ and it wouldn’t surprise me in the least if Aperon is in fact the business of 0M - in other words, it is CIQ.

Soyer talks about it in this podcast from earlier this year

https://open.spotify.com/episode/76GvuPZSPwcSXtIr1eWzRc

52N have been accepted into yet another accelerator program

https://www.linkedin.com/posts/52north_diana-announces-2025-innovator-cohort-activity-7272952413798473728-F8qr?utm_source=share&utm_medium=member_desktop